Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate
European Journal of Cancer · 2025-02 · 216 · 115214
DOI: 10.1016/j.ejca.2024.115214 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025-02. Verfasst von Anna N H Walstra und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diagnostic Accuracy, Groningen, the Netherlands. Hauptthemen laut MEDLINE: Lung Neoplasms, Early Detection of Cancer, Referral and Consultation, Tomography, X-Ray Computed. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Horizon 2020 Framework Programme, EU Framework Programme for Research and Innovation Societal Challenges.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute for Diagnostic Accuracy, Groningen, the Netherlands.
- Institute for Diagnostic Accuracy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands.
- Institute for Diagnostic Accuracy, Groningen, the Netherlands; University of Groningen, University Medical Center Groningen, Department of Epidemiology, Groningen, the Netherlands; Department of Respiratory Medicine, Am…
- Department of Public Health, Erasmus MC - University Medical Center Rotterdam, Rotterdam, the Netherlands.
- Radiology Department, Link2Care Clinics, Bilthoven, the Netherlands.
- Department of Radiology and Nuclear Medicine, Gelre Ziekenhuizen, Apeldoorn, the Netherlands.
Förderung
- Horizon 2020 Framework Programme
- EU Framework Programme for Research and Innovation Societal Challenges
Zitieren
APA
Walstra, A. N. H., Lancaster, H. L., Heuvelmans, M. A., van der Aalst, C. M., Hubert, J., Moldovanu, D., Oudkerk, S. F., Han, D., Gratama, J. W. C., Silva, M., de Koning, H. J., & Oudkerk, M. (2025). Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate. European Journal of Cancer, 216, 115214. https://doi.org/10.1016/j.ejca.2024.115214
Vancouver
Walstra ANH, Lancaster HL, Heuvelmans MA, van der Aalst CM, Hubert J, Moldovanu D, et al. Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate. European Journal of Cancer. 2025;216:115214. doi:10.1016/j.ejca.2024.115214
BibTeX
@article{Walstra2025,
author = {Walstra, Anna N H and Lancaster, Harriet L and Heuvelmans, Marjolein A and van der Aalst, Carlijn M and Hubert, Juul and Moldovanu, Dana and Oudkerk, Sytse F and Han, Daiwei and Gratama, Jan Willem C and Silva, Mario and de Koning, Harry J and Oudkerk, Matthijs},
title = {Feasibility of AI as first reader in the 4-IN-THE-LUNG-RUN lung cancer screening trial: impact on negative-misclassifications and clinical referral rate},
journal = {European Journal of Cancer},
year = {2025},
volume = {216},
pages = {115214},
doi = {10.1016/j.ejca.2024.115214}
}
EUVIMED